IR@PKUHSC  > 北京大学第一临床医学院  > 泌尿外科
学科主题临床医学
Lovastatin Causes Diminished PSA Secretion by Inhibiting AR Expression and Function in LNCaP Prostate Cancer Cells
Yang, Lin; Egger, Martina; Plattner, Raffael; Klocker, Helmut; Eder, Iris E.1
刊名UROLOGY
2011-06-01
DOI10.1016/j.urology.2010.12.074
77期:6
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Urology & Nephrology
资助者Peking University First Hospital, Eurasia-Pacific Uninet ; COMET Center ONCOTYROL ; Federal Ministry for Transport Innovation and Technology (BMVIT) ; Federal Ministry of Economics and Labour/the Federal Ministry of Economy, Family and Youth (BMWA/BMWFJ) ; Tiroler Zukunftsstiftung (TZS) ; Innsbruck Medical University ; Ugichem Gesellschaft fur organische Chemie mbH ; TILAK-Tiroler Landeskrankenanstalten GmbH [TILAK-Hospital Holding Company] ; Peking University First Hospital, Eurasia-Pacific Uninet ; COMET Center ONCOTYROL ; Federal Ministry for Transport Innovation and Technology (BMVIT) ; Federal Ministry of Economics and Labour/the Federal Ministry of Economy, Family and Youth (BMWA/BMWFJ) ; Tiroler Zukunftsstiftung (TZS) ; Innsbruck Medical University ; Ugichem Gesellschaft fur organische Chemie mbH ; TILAK-Tiroler Landeskrankenanstalten GmbH [TILAK-Hospital Holding Company]
研究领域[WOS]Urology & Nephrology
关键词[WOS]COA REDUCTASE INHIBITORS ; ANDROGEN RECEPTOR ; MEVALONATE PATHWAY ; GROWTH-INHIBITION ; DOWN-REGULATION ; CHOLESTEROL ; PROLIFERATION ; P85-ALPHA ; APOPTOSIS ; RISK
英文摘要

OBJECTIVES To investigate why statin users display a noticeable decline in prostate specific antigen (PSA) as revealed in recent clinical trials, we tested the effects of lovastatin on the androgen signaling cascade in lymph node carcinoma of the prostate (LNCaP) prostate cancer cells.

METHODS Effects of lovastatin alone or in combination with a small interference RNA to inhibit AR expression on cell proliferation and induction of apoptosis were assessed by [(3)H] thymidine incorporation and caspase-3 activity assay. PSA levels were measured in the cell culture supernatant by immunoassay. In addition, expression and activity of AR and Akt/protein kinase B (Akt) were determined by Western blotting and real-time polymerase chain reaction as well as by luciferase reporter gene assay.

RESULTS Our results show that lovastatin significantly reduces AR expression and activity, resulting in decreased PSA levels. These effects were associated with inhibition of cell proliferation and induction of apoptosis. In addition, we observed that the Akt signaling pathway plays a pivotal role in lovastatin-mediated regulation of AR signaling.

CONCLUSIONS Our data suggest that the regular use of statins may have beneficial effects in statin users by preventing prostate cancer growth through inhibition of androgen activation and expression, resulting in diminished PSA levels. UROLOGY 77: 1508.e1-1508.e7, 2011. (C) 2011 Elsevier Inc.

语种英语
资助者Peking University First Hospital, Eurasia-Pacific Uninet ; COMET Center ONCOTYROL ; Federal Ministry for Transport Innovation and Technology (BMVIT) ; Federal Ministry of Economics and Labour/the Federal Ministry of Economy, Family and Youth (BMWA/BMWFJ) ; Tiroler Zukunftsstiftung (TZS) ; Innsbruck Medical University ; Ugichem Gesellschaft fur organische Chemie mbH ; TILAK-Tiroler Landeskrankenanstalten GmbH [TILAK-Hospital Holding Company] ; Peking University First Hospital, Eurasia-Pacific Uninet ; COMET Center ONCOTYROL ; Federal Ministry for Transport Innovation and Technology (BMVIT) ; Federal Ministry of Economics and Labour/the Federal Ministry of Economy, Family and Youth (BMWA/BMWFJ) ; Tiroler Zukunftsstiftung (TZS) ; Innsbruck Medical University ; Ugichem Gesellschaft fur organische Chemie mbH ; TILAK-Tiroler Landeskrankenanstalten GmbH [TILAK-Hospital Holding Company]
WOS记录号WOS:000291047500072
引用统计
被引频次:8[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/57618
专题北京大学第一临床医学院_泌尿外科
作者单位1.Peking Univ, Hosp 1, Inst Urol, Beijing 100871, Peoples R China
2.Natl Urol Canc Ctr, Beijing, Peoples R China
3.Innsbruck Med Univ, Dept Urol, Div Expt Urol, A-6020 Innsbruck, Austria
推荐引用方式
GB/T 7714
Yang, Lin,Egger, Martina,Plattner, Raffael,et al. Lovastatin Causes Diminished PSA Secretion by Inhibiting AR Expression and Function in LNCaP Prostate Cancer Cells[J]. UROLOGY,2011,77(6).
APA Yang, Lin,Egger, Martina,Plattner, Raffael,Klocker, Helmut,&Eder, Iris E..(2011).Lovastatin Causes Diminished PSA Secretion by Inhibiting AR Expression and Function in LNCaP Prostate Cancer Cells.UROLOGY,77(6).
MLA Yang, Lin,et al."Lovastatin Causes Diminished PSA Secretion by Inhibiting AR Expression and Function in LNCaP Prostate Cancer Cells".UROLOGY 77.6(2011).
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Yang, Lin]的文章
[Egger, Martina]的文章
[Plattner, Raffael]的文章
百度学术
百度学术中相似的文章
[Yang, Lin]的文章
[Egger, Martina]的文章
[Plattner, Raffael]的文章
必应学术
必应学术中相似的文章
[Yang, Lin]的文章
[Egger, Martina]的文章
[Plattner, Raffael]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。